Abstract: An operation state display device displays an operation state of a board production facility in which a board is sequentially conveyed to multiple board work machines, which perform predetermined board work on the board, and the board work is sequentially performed to produce a board product, and includes an acquisition section and a display section. The acquisition section acquires an execution time zone in which setup changing work required for switching a type of the board product to be produced is performed, for each board work machine, based on production information acquired by the board production facility during production of the board product. The display section graphically displays at least one of the execution time zone for each of the multiple board work machines and the execution time zone for a predetermined board work machine of the board production facility in time series.

Abstract: An operation status display device displays an operation status of a board work machine, in which an operator replenishes an article to be used in production of a board product, and the operation status display device includes an acquisition section and a display section. The acquisition section is configured to acquire a first time, which is a wait time from when the article is insufficient in the board work machine to when the operator starts replenishment work of the article, and a second time, which is a work time from when the operator starts the replenishment work to when the article is replenished in the board work machine. The display section is configured to display the first time and the second time when the article is insufficient in the board work machine to when the article is replenished.

Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.

Abstract: A speech processing system includes one or more analog microphones each arrangeable within a cabin and configured to output a first analog speech signal, one or more digital microphones each arrangeable within the cabin and configured to output a digital speech signal, a digital-to-analog convertor configured to convert the digital speech signal into a second analog speech signal, and a speech signal processer including a delay processer configured to delay at least the first analog speech signal on the basis of a delay time period when the digital-to-analog convertor converts the digital speech signal, which is collected at the same time point as the first analog speech signal, into the second analog speech signal and output the delayed first analog speech signal as a third analog speech signal and configured to perform speech signal processing on the basis of the second analog speech signal and the third analog speech signal.

Abstract: An aqueous ink jet composition includes a first component which is at least one selected from the group consisting of C.I. Solvent Yellow 160: 1, C.I. Disperse Yellow 82, and C.I. Disperse Yellow 184; a second component which is a dispersant having at least one chemical structure of a sulfo group and a salt thereof; and a third component which has a coumarin skeleton and at least one chemical structure of a sulfo group and a salt thereof.

Abstract: A film capacitor that includes a laminate having a first resin film including a first metal layer on a surface thereof alternately laminated with a second resin film including a second metal layer on a surface thereof, the laminate having opposed first and second ends, a first external electrode on the first end of the laminate, and a second external electrode on the second end of the laminate, wherein the first resin film protrudes more than the second resin film by a first protruding length of 0.5 mm to 3 mm on the first end of the laminate, and the first resin film has a Young's modulus at 150° C. of 0.6 GPa or more in a direction perpendicular to a lamination direction of the laminate and parallel to a direction from the first end to the second end of the laminate.

Abstract: An aqueous ink jet composition contains at least one disperse dye selected from the group consisting of C.I. Disperse Yellow 54, C.I. Disperse Red 60, and C.I. Disperse Blue 359, and a styrene maleic acid-based dispersing agent represented by Formula (1).

Abstract: The present disclosure provides an energy management system capable of improving energy efficiency. The energy management system includes: a fuel cell configured to supply energy used in a facility; a first hydrogen supply unit configured to supply hydrogen to the fuel cell by causing a power generation apparatus that uses renewable energy to perform water electrolysis; a second hydrogen supply unit configured to supply hydrogen to the fuel cell by reforming natural gas supplied via a pipeline; and a control unit configured to determine a ratio between hydrogen supplied from the first hydrogen supply unit to the fuel cell and hydrogen supplied from the second hydrogen supply unit to the fuel cell. The control unit determines the ratio in accordance with a percentage of heat energy and energy other than the heat energy with respect to the energy used in the facility.

Abstract: An agent device includes one or more agent controllers configured to provide a service including causing an output device to output a response of voice according to a voice of an occupant which is collected in a vehicle interior of a vehicle, a receiver configured to receive an input from the occupant, and a starting method setter configured to change or add a starting method of the agent controller on the basis of content received by the receiver.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Abstract: The present invention aims to provide a new method for producing an indole compound or a salt thereof, which has an ITK inhibitory action, and is useful for the prophylaxis or treatment of inflammatory disease.

Abstract: Provided is an information processing apparatus including an acquiring unit that acquires cell information indicating a state of a cell from production of a pluripotent stem cell to differentiation of the pluripotent stem cell into a specific differentiated cell by differentiation induction, and process history information indicating a history of a processing process for obtaining the differentiated cell, and a deriving unit that derives differentiation potency information indicating differentiation potency of the pluripotent stem cell based on the cell information and the process history information which are acquired by the acquiring unit.

Abstract: An agent device includes one or more agent controllers configured to provide a service including causing an output device to output a response of voice according to a voice of an occupant which is collected in a vehicle interior of a vehicle, a receiver configured to receive an input from the occupant, and a starting method setter configured to change or add a starting method of the agent controller on the basis of content received by the receiver.

Abstract: An agent device includes: a plurality of agent function units, each of the plurality of agent function units being configured to provide services including outputting a response to an output unit in response to an utterance of an occupant of a vehicle; a recognizer configured to recognize a request included in the occupant's utterance; and an agent selector configured to output a request recognized by the recognizer to the plurality of agent function units and select an agent function unit which outputs a response to the occupant's utterance to the output unit among the plurality of agent function units on the basis of the result of a response of each of the plurality of agent function units.

Abstract: An agent device includes: a plurality of agent function units, in which each of the agent function units provides a service including a voice response to an occupant of a vehicle in response to an utterance of the occupant; and a manager which, when any of the plurality of agent function units is being activated and the predetermined same operation is performed on the plurality of agent function units by the occupant of the vehicle, causes the agent function unit which is being activated to stop.

Abstract: Provided is an agent for the treatment or prophylaxis of inflammatory diseases, allergic diseases, autoimmune diseases, transplant rejection or the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as described in the specification.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: A semiconductor memory device includes a substrate, a controller, a semiconductor memory component, first and second capacitors, and a jumper element. The substrate has a conductor pattern. The conductor pattern includes a first conductor portion and a second conductor portion. The first conductor portion overlaps at least a part of the first capacitor in a thickness direction of the substrate and is electrically connected to the first capacitor. The second conductor portion overlaps at least a part of the second capacitor in the thickness direction of the substrate and is electrically connected to the second capacitor. The first conductor portion and the second conductor portion are separated from each other, and are electrically connected to each other by the jumper element.

Abstract: The present invention relates to a pyrimidine compound or a pharmaceutically acceptable salt thereof represented by the following formula [I] wherein each symbol is as defined in the specification and a method of therapeutically or prophylactically treating an undesirable cell proliferation, comprising administering such a compound. The compound of the present invention has superior activity in suppressing undesirable cell proliferation, particularly, an antitumor activity, and is useful as an antitumor agent for the prophylaxis or treatment of cancer, rheumatism, and the like. In addition, the compound of the present invention can be a more effective antitumor agent when used in combination with other antitumor agents such as an alkylating agent or metabolism antagonist.